Schwab Charles CORP Form 4 insider transactions

Director Carolyn Schwab-Pomerantz was granted 1,602 restricted stock units and 3,977 stock options as part of the 2022 Stock Incentive Plan.

Director Joan Dea acquired 1,602 restricted stock units and 3,977 stock options as part of the 2022 Stock Incentive Plan.

Charles Schwab President and CEO Richard A. Wurster purchased 21,959 shares of company common stock on May 28, 2026.

Director Marianne Brown acquired 1,602 restricted stock units and 3,977 stock options as part of a standard equity incentive plan.

Charles Schwab Corporation Director Christopher V. Dodds was granted restricted stock units and stock options under the company's 2022 Stock Incentive Plan.

Charles Schwab Corporation Director Frank Herringer was granted restricted stock units and stock options as part of the company's 2022 Stock Incentive Plan.

Director Paula A. Sneed was granted restricted stock units and stock options as part of the company's 2022 Stock Incentive Plan.

Charles Schwab Corporation director Stephen A. Ellis was granted restricted stock units and stock options as part of the company's 2022 Stock Incentive Plan.

Charles Schwab Corporation director Arun Sarin was granted 1,602 restricted stock units and 3,977 stock options as part of the company's 2022 Stock Incentive Plan.

Charles R. Schwab, Co-Chairman and Director of The Charles Schwab Corporation, reported significant changes in beneficial ownership of common stock on May 22, 2026.

Joan Dea, a Director at The Charles Schwab Corporation, has filed a Form 4 detailing a transaction of common stock.

Charles R. Schwab, Co-Chairman of The Charles Schwab Corporation, reported the sale of 27,500 shares of common stock.

Co-Chairman Charles R. Schwab reported the sale of 27,500 shares and a gift of 5,300 shares of Charles Schwab Corp common stock.

Director Arun Sarin exercised stock options for 7,866 shares and sold a portion of the resulting holdings.

Director Carolyn Schwab-Pomerantz exercised stock options and sold 9,910 shares of Charles Schwab Corporation common stock.

Charles R. Schwab, Co-Chairman of Charles Schwab Corp, reported the sale of 218,600 shares of common stock via a limited partnership.

Co-Chairman Charles R. Schwab reported the sale of 168,743 shares of common stock across three trading days.

Director Frank C. Herringer exercised 7,866 stock options and sold a portion of the resulting shares in The Charles Schwab Corporation.

Charles R. Schwab, Co-Chairman of The Charles Schwab Corporation, reported the sale of 72,900 shares of common stock held in trust.

Charles Schwab Chief Banking Officer Paul Woolway exercised stock options and sold shares under a pre-arranged 10b5-1 trading plan.

Jonathan M. Craig, MD of Retail Investing at Charles Schwab, exercised 21,750 stock options and sold the resulting shares.

Chief Risk Officer Nigel J. Murtagh exercised 41,297 stock options and sold the resulting shares under a 10b5-1 plan.

Director Marianne Catherine Brown acquired restricted stock units in Charles Schwab Corp. (SCHW) on April 1, 2026, as part of the Directors' Deferred Compensation Plan II.

Charles Ruffel, a Director at Charles Schwab Corp., acquired stock options valued at $92.36 per share on April 1, 2026, as part of the Directors' Deferred Compensation Plan.

Frank C. Herringer, a Director at Charles Schwab Corp., acquired restricted stock units as part of his compensation.

Director Stephen A. Ellis acquired 393 Restricted Stock Units (RSUs) of Charles Schwab Corp. on April 1, 2026, as part of the Directors' Deferred Compensation Plan.

Charles Schwab Director Stephen A. Ellis reported exercising nonqualified stock options, acquiring 9,765 shares of common stock.

Charles Schwab's Chief Risk Officer, Nigel J. Murtagh, sold 7,203 shares of common stock for approximately $682,000 under a pre-arranged trading plan.

A Schwab executive sold common stock totaling 14,481 shares on March 3, 2026, under a pre-arranged 10b5-1 trading plan.

A Charles Schwab Corporation executive sold over 10,000 shares of common stock on March 3, 2026, under a pre-arranged trading plan.